{"id":"W2060420423","doi":"10.1016/j.jcjd.2014.07.011","title":"Efficacy and Safety of Once Weekly Dulaglutide vs. Insulin Glargine in Combination with Metformin and Glimepiride in Type 2 Diabetes Patients (AWARD-2)","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Glimepiride; Medicine; Dulaglutide; Metformin; Type 2 diabetes; Insulin glargine; Diabetes mellitus; Internal medicine; Exenatide; Pharmacology; Insulin; Endocrinology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001301125,0.0008304422,0.003438849,0.0004366752,0.0003478079,0.001191216,0.0008378825,0.00110408,0.003268633],"category_scores_gemma":[0.001677262,0.000495007,0.00220685,0.0005369753,0.0005100661,0.001402693,0.0004230409,0.002438427,0.0005353767],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008952334,"about_ca_system_score_gemma":0.0008542292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001338441,"about_ca_topic_score_gemma":0.002761493,"domain_scores_codex":[0.9993412,0.0002577958,0.00006253084,0.0001389432,0.00007417687,0.0001252572],"domain_scores_gemma":[0.9989244,0.0002118857,0.0002108116,0.00009746495,0.00005751255,0.0004979578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9352899,0.008599259,0.00683342,0.0002215557,0.001148019,0.00005951195,0.00005018387,0.0003467341,0.003299364,0.00004589216,0.0003655694,0.04374063],"study_design_scores_gemma":[0.4943256,0.4100696,0.08607469,0.0001299584,0.003370536,0.000287915,0.0001909056,0.001850383,0.002105485,0.0002071418,0.00127763,0.0001101359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959342,0.002451727,0.00008014216,0.0001757959,0.0001177876,0.00008689939,0.0003067204,0.00002943762,0.0008173199],"genre_scores_gemma":[0.9973212,0.0008919187,0.0002383817,0.0001967303,0.0001517159,0.0000955857,0.0004132196,0.000009682212,0.000681603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003438849,"threshold_uncertainty_score":0.01093465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00551360031396662,"score_gpt":0.2006108537760123,"score_spread":0.1950972534620457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}